Label: NALOXONE HYDROCHLORIDE spray

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated June 27, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active Ingredient (in each spray)

    Naloxone hydrochloride 4 mg

  • Purpose

    Emergency treatment of opioid overdose

  • Uses

    •to “revive” someone during an overdose from many prescription pain medicationsor street drugs such as heroin

    •this medicine can save a life

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.

  • Directions

    Step 1

    Step 1: CHECK if you suspect an overdose:

    • CHECKfor a suspected overdose: the person will not wake up or is very sleepy or not breathing well

    •yell “Wake up!”

    •shake the person gently

    •if the person is not awake, go to Step 2

    Step 2

    Step 2: GIVE 1st dose in the nose

    • HOLDthe nasal spray device with your thumb on the bottom of the plunger

    • INSERTthe nozzle into either NOSTRIL

    • PRESSthe plunger firmly to give the 1st dose

    •1 nasal spray device contains 1 dose

    Step 3

    Step 3: CALL

    • CALL 911immediately after giving the 1st dose

    Step 4

    Step 4: WATCH & GIVE

    • WAIT2-3 minutes after the 1st dose to give the medicine time to work

    •if the person wakes up: Go to Step 5

    •if the person does not wake up:

       • CONTINUE TO GIVEdoses every 2-3 minutes until the person wakes up

        •it is safe to keep giving doses

    Step 5

    Step 5: STAY

    • STAYuntil ambulance arrives: even if the person wakes up

    • GIVEanother dose if the person becomes very sleepy again

    •You may need to give all the doses in the pack

  • Warning

    When using this productsome people may experience symptoms when they wake up, such as shaking, sweating, nausea, or feeling angry. This is to be expected.

  • Other information

    •store at room temperature or refrigerated, between 2°C to 25°C (36°F to 77°F)

    •do not freeze

    •avoid excessive heat above 40°C (104°F)

    •protect from light

    •the product is packaged in individually-sealed blisters.

       Do not use if the blister is open or torn, or if the device appears damaged

  • Inactive Ingredients

    benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, water

  • Questions?

    • call 1-866-634-9120 or go to www.padagis.com
  • Package/Label Principal Display Panel

    NDC: 80425-0409-01

    Naloxone HCl Nasal Spray 4 mg

    Emergency Treatment of Opioid Overdose

    Original Prescription Strength

    Easy to Use

    Can Save a Life

    Designed to Rapidly Reverse the Effects of a Life-Threatening Opioid Emergency

    For use in nose only

    2 Single-Dose Nasal Spray Devices

    0.003 fl oz (0.1mL) each

    Naloxone HCl Nasal Spray #2

  • INGREDIENTS AND APPEARANCE
    NALOXONE HYDROCHLORIDE 
    naloxone hydrochloride spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:80425-0409(NDC:45802-578)
    Route of AdministrationNASAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NALOXONE HYDROCHLORIDE (UNII: F850569PQR) (NALOXONE - UNII:36B82AMQ7N) NALOXONE HYDROCHLORIDE4 mg  in 0.1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:80425-0409-12 in 1 CARTON06/27/2024
    10.1 mL in 1 VIAL, SINGLE-DOSE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21195106/27/2024
    Labeler - Advanced Rx of Tennessee, LLC (117023142)
    Establishment
    NameAddressID/FEIBusiness Operations
    Advanced Rx of Tennessee, LLC117023142repack(80425-0409)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!